Darrin Disley Overview

  • Investor Type
  • Angel

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 6

  • Portfolio
  • 2

  • Exits
  • 3

Exits

Darrin Disley General Information

Description

Dr. Darrin Disley serves as Co-Chief Executive Officer at Horizon Genomics. He serves as Advisory Board Member at Sana Capital. He served as Board Member at Healx. He co-founded and served as Board Member at GeoSpock. He serves as Chairman at Celixir. He also served as President, Chief Executive Officer & Board Member at Horizon Discovery. He is a successful serial entrepreneur who has been involved in the start-up and growth of a number of business ventures. Since joining in 2007, he has been instrumental in growing Horizon from a small start-up in Cambridge in the UK into a rapidly growing multinational leader in the life sciences. During this time, he has built a world-class management team, set the commercial and business strategy, led the company through multiple financing rounds including the Company's highly successful IPO in 2014, and driven the acquisitions of CombinatoRx, Sage Labs, Haplogen Genomics, and Avvinity Therapeutics. He is the holder of multiple business awards including Scrip Executive of the Year in 2014, a global award recognizing leadership in biotechnology and pharmaceutical companies, UK quoted company Entrepreneur of the Year in 2015 and was recently conferred with a lifetime held Queens Award for Enterprise Promotion by Her Majesty Queen Elizabeth the II in recognition of his contribution to Life Science entrepreneurship. He is a strong supporter of numerous academic, entrepreneurship, and mentoring programs across the UK. He also sits on the Boards of several companies and organizations including Cell Therapy Ltd, Desktop Genetics Ltd, and the UK Bioindustry Association, and is an Angel investor in over 30 UK companies in the technology and life science sectors. He holds a Ph.D. in Biotechnology from the University of Cambridge. He also served as an Advisor, Life Sciences at Bailey Fisher Executive Search.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Corporate Office
  • Cambridge
  • England, United Kingdom

Darrin Disley Investments (6)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
bit.bio 16-Nov-2017 Seed Round 00000 Drug Discovery Generating Revenue 000000 000000 00.0
GeneAdviser 02-Jun-2016 0000 00000 00000 Information Services (B2C) Out of Business 000000 000000 00.0
Axol (Biotechnology) 24-Mar-2016 000000 00000 00.000 Biotechnology Generating Revenue 000000 000000 00.0
GeoSpock 07-Oct-2015 00000 00000 00.000 Database Software Bankruptcy: Liquidation 000000 000000 00.0
Genomes Unzipped 15-Sep-2015 Early Stage VC 00.000 Information Services (B2C) Generating Revenue 000000 000000 00.0
Genomes Unzipped 29-Aug-2013 Early Stage VC 00000 Information Services (B2C) Generating Revenue 000000 000000 00.0

Darrin Disley Exits (3)

Company Name Exit Date Exit Type Exit Size
GeoSpock 14-Jun-2023 Bankruptcy: Liquidation
Genomes Unzipped 01-Jun-2018 000000000000000000
GeneAdviser 21-Jun-2017 000 00 00000000

Darrin Disley Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Darrin Disley Team (1)

Name Title Deals Funds Boards Office
Darrin Disley Ph.D Angel Investor 00 0 Cambridge, United Kingdom

Darrin Disley FAQs

  • Who is Darrin Disley?

    Darrin Disley is an angel Investor who has made 6 investments.

  • What kind of investor is Darrin Disley?

    Darrin Disley is an angel investor.

  • What does Darrin Disley do?

    As an angel investor, Darrin Disley invests personal money into promising companies, typically in exchange for equity.

  • What has Darrin Disley invested in?

    Darrin Disley has made numerous investments in companies like bit.bio, GeneAdviser, and Axol (Biotechnology) within the Drug Discovery, Information Services (B2C), and Biotechnology industries.

  • What has Darrin Disley invested in recently?

    Darrin Disley's latest investment was on 16-Nov-2017 in bit.bio, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »